Equities

MedCap AB (publ)

MedCap AB (publ)

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (SEK)467.00
  • Today's Change40.50 / 9.50%
  • Shares traded35.29k
  • 1 Year change+59.93%
  • Beta0.6823
Data delayed at least 15 minutes, as of May 03 2024 13:44 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

MedCap AB (publ) is a Sweden-based private equity company engaged in investments in and development of companies active primarily within the medical equipment sector. The Company reports four segments: Abilia, Unimedic, Quickels and Inpac. The Company’s portfolio includes such companies as Abilia AB, which is engaged in the development and marketing of aids within the fields of communication, cognition, noise and environmental control; Unimedic AB, engaged in contract manufacturing of liquid pharmaceuticals; Quickels Systems AB, which is engaged in the development and marketing of intensive medical care equipment, such as care bags and electrocardiogram (ECG) equipment; AirContainer Package System AB that offers a wide range of packaging solutions for the pharmaceutical industry, and Dunmedic AB, which offers medical products, medicines and food supplements.

  • Revenue in SEK (TTM)1.59bn
  • Net income in SEK172.10m
  • Incorporated2001
  • Employees476.00
  • Location
    MedCap AB (publ)Engelbrektsgatan 9-1STOCKHOLM 114 32SwedenSWE
  • Phone+46 8347110
  • Websitehttps://www.medcap.se/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
MCAP:STO since
announced
Transaction
value
SurgiCube International BVAnnounced24 Jul 202324 Jul 2023Announced77.90%--
Data delayed at least 15 minutes, as of May 03 2024 13:44 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
VNV Global AB (publ)-503.83m-663.37m3.38bn10.00--0.4787-----5.16-5.16-4.1753.88-0.0562-----50,382,910.00-7.40-6.17-7.98-6.33-----------16.630.1412--105.9745.89102.87------
Teqnion AB1.51bn117.00m3.38bn482.0028.364.3719.392.256.956.9589.2245.131.113.287.303,122,822.008.6810.4412.0314.9345.6242.547.797.901.2310.230.33992.0611.3837.8813.3336.9146.21--
Linc AB384.44m401.01m3.85bn2.009.601.07--10.026.926.926.6462.000.1131--46.29192,222,000.0011.809.7611.809.76----104.3198.02----0.00--173.9116.70185.6414.42----
Traction AB1.20m269.80m3.96bn3.0015.291.05--3,301.5018.2418.240.0811265.360.0003----400,000.006.989.477.009.48----22,483.3318,145.55----0.0027.440.00-5.59171.41----23.76
Treasure ASA0.00916.81m4.01bn0.004.390.5439----4.514.510.0036.460.00------12.8810.7612.8910.76------887.92----0.00262.19-----15.28----26.72
Humble Group AB7.05bn-105.00m4.35bn1.13k--0.892718.420.6167-0.24-0.2418.6410.980.79325.7911.336,243,579.00-1.18-2.02-1.49-2.4719.2919.19-1.49-3.130.61130.96050.2672--46.88365.75-194.44------
Bergman & Beving AB4.75bn195.00m5.95bn1.28k30.942.7612.471.257.297.29177.3881.770.82061.875.503,520,772.003.563.684.875.3046.8042.484.344.010.87326.210.446345.183.804.383.505.559.187.57
MedCap AB (publ)1.59bn172.10m6.32bn476.0036.836.1722.843.9811.5811.58106.8569.081.033.877.813,334,874.0011.169.0114.1412.0046.5046.7710.879.841.4244.280.20280.0042.8417.4946.4347.822.82--
Svolder AB-81.60m-110.10m6.57bn5.00--1.13-----1.34-1.34-0.788955.07-0.0142-----16,320,000.00-1.9110.20-1.9210.26--96.56--94.54----0.0015.0957.64--55.69--0.0014.87
RVRC Holding AB1.73bn289.00m6.79bn118.0023.575.6222.873.922.552.5515.3110.711.131.093,462.0012,822,220.0018.86--24.74--72.10--16.70--0.9904123.330.0736--17.21---15.63------
Data as of May 03 2024. Currency figures normalised to MedCap AB (publ)'s reporting currency: Swedish Krona SEK

Institutional shareholders

41.04%Per cent of shares held by top holders
HolderShares% Held
Lannebo Fonder ABas of 31 Dec 20231.27m8.59%
SEB Investment Management ABas of 28 Mar 2024761.40k5.14%
Spiltan Fonder ABas of 31 Aug 2023710.32k4.80%
Swedbank Robur Fonder ABas of 29 Feb 2024692.00k4.67%
Tredje AP-fondenas of 31 Aug 2023500.00k3.38%
Alcur Fonder ABas of 31 Aug 2023483.09k3.26%
Andra AP-fondenas of 31 Aug 2023456.22k3.08%
ODIN Forvaltning AS (Sweden)as of 31 Aug 2023450.00k3.04%
Nordea Investment Management ABas of 31 Dec 2023401.74k2.71%
Cliens Kapitalf�rvaltning ABas of 31 Mar 2024349.86k2.36%
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.